NHS vs. NMANX
Compare and contrast key facts about Neuberger Berman High Yield Strategies Fund (NHS) and Neuberger Berman Mid Cap Growth Fund (NMANX).
NHS is an actively managed fund by Neuberger Berman. It was launched on Jul 28, 2003. NMANX is managed by Neuberger Berman. It was launched on Mar 1, 1979.
Performance
NHS vs. NMANX - Performance Comparison
Loading graphics...
NHS vs. NMANX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NHS Neuberger Berman High Yield Strategies Fund | -9.47% | 14.81% | 11.04% | 6.12% | -22.99% | 15.78% | 4.57% | 39.03% | -11.45% | 8.64% |
NMANX Neuberger Berman Mid Cap Growth Fund | -5.12% | 5.51% | 24.39% | 18.21% | -28.82% | 12.42% | 39.45% | 33.62% | -6.28% | 29.01% |
Returns By Period
In the year-to-date period, NHS achieves a -9.47% return, which is significantly lower than NMANX's -5.12% return. Over the past 10 years, NHS has underperformed NMANX with an annualized return of 6.10%, while NMANX has yielded a comparatively higher 11.06% annualized return.
NHS
- 1D
- 0.15%
- 1M
- -14.94%
- YTD
- -9.47%
- 6M
- -6.82%
- 1Y
- -1.78%
- 3Y*
- 5.86%
- 5Y*
- -0.76%
- 10Y*
- 6.10%
NMANX
- 1D
- 4.27%
- 1M
- -6.96%
- YTD
- -5.12%
- 6M
- -12.25%
- 1Y
- 8.94%
- 3Y*
- 10.91%
- 5Y*
- 2.51%
- 10Y*
- 11.06%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NHS vs. NMANX - Expense Ratio Comparison
NHS has a 4.14% expense ratio, which is higher than NMANX's 0.83% expense ratio.
Return for Risk
NHS vs. NMANX — Risk / Return Rank
NHS
NMANX
NHS vs. NMANX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neuberger Berman High Yield Strategies Fund (NHS) and Neuberger Berman Mid Cap Growth Fund (NMANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NHS | NMANX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.11 | 0.42 | -0.53 |
Sortino ratioReturn per unit of downside risk | -0.04 | 0.74 | -0.79 |
Omega ratioGain probability vs. loss probability | 0.99 | 1.09 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | -0.09 | 0.44 | -0.54 |
Martin ratioReturn relative to average drawdown | -0.41 | 1.39 | -1.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NHS | NMANX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.11 | 0.42 | -0.53 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.11 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.50 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.50 | -0.15 |
Correlation
The correlation between NHS and NMANX is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
NHS vs. NMANX - Dividend Comparison
NHS's dividend yield for the trailing twelve months is around 16.73%, less than NMANX's 24.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NHS Neuberger Berman High Yield Strategies Fund | 16.73% | 14.60% | 14.50% | 13.94% | 12.75% | 8.74% | 9.29% | 7.99% | 8.37% | 7.59% | 8.23% | 9.81% |
NMANX Neuberger Berman Mid Cap Growth Fund | 24.34% | 23.10% | 9.85% | 3.19% | 4.87% | 16.30% | 9.58% | 5.43% | 11.70% | 8.94% | 5.00% | 9.00% |
Drawdowns
NHS vs. NMANX - Drawdown Comparison
The maximum NHS drawdown since its inception was -64.67%, smaller than the maximum NMANX drawdown of -72.14%. Use the drawdown chart below to compare losses from any high point for NHS and NMANX.
Loading graphics...
Drawdown Indicators
| NHS | NMANX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.67% | -72.14% | +7.47% |
Max Drawdown (1Y)Largest decline over 1 year | -17.43% | -17.71% | +0.28% |
Max Drawdown (5Y)Largest decline over 5 years | -37.43% | -38.10% | +0.67% |
Max Drawdown (10Y)Largest decline over 10 years | -42.97% | -38.10% | -4.87% |
Current DrawdownCurrent decline from peak | -14.94% | -14.20% | -0.74% |
Average DrawdownAverage peak-to-trough decline | -8.82% | -17.45% | +8.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.00% | 5.65% | -1.65% |
Volatility
NHS vs. NMANX - Volatility Comparison
The current volatility for Neuberger Berman High Yield Strategies Fund (NHS) is 6.23%, while Neuberger Berman Mid Cap Growth Fund (NMANX) has a volatility of 8.87%. This indicates that NHS experiences smaller price fluctuations and is considered to be less risky than NMANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NHS | NMANX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.23% | 8.87% | -2.64% |
Volatility (6M)Calculated over the trailing 6-month period | 10.99% | 16.47% | -5.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.02% | 23.78% | -7.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.17% | 23.16% | -6.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.67% | 22.36% | -5.69% |